Anti-CD28L/CD80 Antibody (Galiximab)
Catalog No.
F1163
Anti-CD28L/CD80 Antibody (Galiximab)
Featured Products
Galiximab (IDEC 114) is an immunoglobulin G1 (IgG1) monoclonal antibody that targets the CD80 antigen and blocks CD80–CD28 binding. The variable region of Galiximab is primate and the constant region is human. Galiximab can be used in the study of B-cell lymphoma.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.24 kDa
Dry ice
357613-77-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
IDEC-114, IDEC-114-20
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P33681
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD28L / CD80
Please avoid freeze-thaw cycles.